These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31570139)

  • 21. Mediation Analysis With Matched Case-Control Study Designs.
    VanderWeele TJ; Tchetgen Tchetgen EJ
    Am J Epidemiol; 2016 May; 183(9):869-70. PubMed ID: 27076669
    [No Abstract]   [Full Text] [Related]  

  • 22. Some old and some new statistical tools for outcomes research.
    Normand SL
    Circulation; 2008 Aug; 118(8):872-84. PubMed ID: 18711024
    [No Abstract]   [Full Text] [Related]  

  • 23. SAS macro for causal mediation analysis with survival data.
    Valeri L; VanderWeele TJ
    Epidemiology; 2015 Mar; 26(2):e23-4. PubMed ID: 25643116
    [No Abstract]   [Full Text] [Related]  

  • 24. Power analysis: Part II.
    Lederman RP; Worsham S
    MCN Am J Matern Child Nurs; 1994; 19(1):45. PubMed ID: 8201862
    [No Abstract]   [Full Text] [Related]  

  • 25. Pooled exposure assessment for matched case-control studies.
    Saha-Chaudhuri P; Umbach DM; Weinberg CR
    Epidemiology; 2011 Sep; 22(5):704-12. PubMed ID: 21747285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redressing the balance: Covariate adjustment in randomised trials.
    Kahan BC; Morris TP
    BJOG; 2021 Sep; 128(10):1573. PubMed ID: 34124821
    [No Abstract]   [Full Text] [Related]  

  • 27. Statistical methods for preventive trials in mental health.
    Brown CH
    Stat Med; 1993 Feb; 12(3-4):289-300. PubMed ID: 7681214
    [No Abstract]   [Full Text] [Related]  

  • 28. Using extended Rasch models to assess validity of diagnostic tests in the presence of a reference standard.
    Viallon V; Ecosse E; Mesbah M; Pouchot J; Coste J
    J Appl Meas; 2012; 13(4):376-93. PubMed ID: 23270981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for individual and population equivalence based on the proportion of similar responses.
    Senn S
    Stat Med; 1997 Jun; 16(11):1303-6. PubMed ID: 9194274
    [No Abstract]   [Full Text] [Related]  

  • 30. A principal stratification approach for evaluating natural direct and indirect effects in the presence of treatment-induced intermediate confounding.
    Taguri M; Chiba Y
    Stat Med; 2015 Jan; 34(1):131-44. PubMed ID: 25312003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical epidemiology and biostatistics: a primer for orthopaedic surgeons.
    Kocher MS; Zurakowski D
    J Bone Joint Surg Am; 2004 Mar; 86(3):607-20. PubMed ID: 14996892
    [No Abstract]   [Full Text] [Related]  

  • 32. Measuring balance and model selection in propensity score methods.
    Belitser SV; Martens EP; Pestman WR; Groenwold RH; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1115-29. PubMed ID: 21805529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fast FSR variable selection with applications to clinical trials.
    Boos DD; Stefanski LA; Wu Y
    Biometrics; 2009 Sep; 65(3):692-700. PubMed ID: 18945266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dichotomising dangers.
    Bangdiwala SI
    Int J Inj Contr Saf Promot; 2014; 21(3):298-300. PubMed ID: 25078030
    [No Abstract]   [Full Text] [Related]  

  • 35. Invited commentary: Advancing theory and methods for multilevel models of residential neighborhoods and health.
    O'Campo P
    Am J Epidemiol; 2003 Jan; 157(1):9-13. PubMed ID: 12505885
    [No Abstract]   [Full Text] [Related]  

  • 36. Causal theory and the etiology of periodontal diseases.
    Heaton B; Dietrich T
    Periodontol 2000; 2012 Feb; 58(1):26-36. PubMed ID: 22133365
    [No Abstract]   [Full Text] [Related]  

  • 37. Applying the E Value to Assess the Robustness of Epidemiologic Fields of Inquiry to Unmeasured Confounding.
    Trinquart L; Erlinger AL; Petersen JM; Fox M; Galea S
    Am J Epidemiol; 2019 Jun; 188(6):1174-1180. PubMed ID: 30874728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying subjects who benefit from additional information for better prediction of the outcome variables.
    Tian L; Cai T; Wei LJ
    Biometrics; 2009 Sep; 65(3):894-902. PubMed ID: 18945268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding research: 2. Ensuring reliability and validity.
    Baxter H
    J Wound Care; 2001 Sep; 10(8):329-31. PubMed ID: 12964336
    [No Abstract]   [Full Text] [Related]  

  • 40. Confounding and effect modification: possible explanation for variation in the results on the association between oral and systemic diseases.
    Ylöstalo PV; Knuuttila ML
    J Clin Periodontol; 2006 Feb; 33(2):104-8. PubMed ID: 16441733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.